Lanzamiento Enero 2027

Ensayo controlado aleatorizado2022Financiado por la industria

Financiado en parte por Danone

Whole grain germinated brown rice regulates intestinal immune homeostasis and gastrointestinal hormones in type 2 diabetic patients-a randomized control trial

Ding Q, Ren J, Zhou Y, Bai Z, Yan J, Na G, Shan Y

Food & function · 15 citas

Etiquetas de revisión

Financiado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiado por la industria
Empresa
Danone
Gobierno
Natural Science Foundation of Zhejiang Province
Subvenciones
Natural Science Foundation of Zhejiang Province (LY21H260004); Danone (DIC2016-05)

Según 2 financiadores declarados.

Publicación

Publicado
2022-01-01 · Food Funct · vol. 13 · número 15 · págs. 8274–8282
Editorial
Royal Society of Chemistry
Citado
25 citas · más que el 92% de estudios similares · 3.6× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
20 trabajos
Acceso
De pago
Áreas de investigación
GABA and Rice Research · Gut microbiota and health · Nutrition, Genetics, and Disease
Palabras clave
Glycated hemoglobin, Bacteroides, Brown rice, Internal medicine, Type 2 diabetes, Immune system, Hormone, Type 2 Diabetes Mellitus, Glycemic, Feces, Food science, Resistin, Medicine, Endocrinology, Biology, Diabetes mellitus, Immunology, Insulin, Insulin resistance, Bacteria, Adipokine, Microbiology
MeSH
humans, diabetes mellitus, type 2, gastrointestinal hormones, blood glucose, homeostasis, aged, middle aged, oryza, whole grains

7 autores

  • Qi Ding🇨🇳Wenzhou Medical University
  • Junli Ren🇨🇳Harbin Institute of Technology
  • Yingying Zhou🇨🇳Wenzhou Medical University
  • Zhihuai Bai🇨🇳Wenzhou Medical University
  • Jielin Yan🇨🇳Wenzhou Medical University
  • Guanqiong Na🇨🇳Wenzhou Medical University
  • Yujuan Shan🇨🇳Wenzhou Medical University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background: Whole grains present distinguished benefits to a handful of metabolic syndromes (MetS). However, the preventive effects of germinated brown rice (GBR), a new type of brown rice, on patients with type 2 diabetes (T2DM) are rarely reported. Objectives: To investigate whether replacing 100 g refined white rice (RWR) with equal GBR per day is effective in T2DM and its underlying mechanisms. Methods: Ninety-nine qualified T2DM patients (64.58 ± 5.06 years old) were recruited. All patients were randomly divided into GBR group (100 g d-1 GBR for 12 weeks) and control group (keep the regular diet). Food frequency questionnaires, and fresh stool and serum samples were collected before and after the intervention, followed by various measurements. Results: Fasting blood glucose was obviously decreased after GBR intervention with an effective rate of 62%. Glycated hemoglobin (HbA1c) levels were decreased in the GBR group with no significance. In the GBR group, the abundance of beneficial bacteria in feces was increased, while harmful bacteria were decreased. The percentage of Bacteroides (57.2%) was largely increased. In addition, three types of short-chain fatty acids (SCFAs) including acetic acid, propanoic acid, and butyric acid were increased significantly by GBR (p p Conclusions: GBR (100 g d-1 for 12 weeks) has positive improvement in the fasting blood glucose for T2DM patients, which attributed to the recovery of intestinal homeostasis.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.